Insufficient scRNA-seq data for expression of PRMT6 at single-cell level.
Insufficient scRNA-seq data for expression of PRMT6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 839.28 | 245 / 245 | 100% | 30.09 | 501 / 502 |
ovary | 100% | 681.73 | 180 / 180 | 100% | 19.91 | 429 / 430 |
brain | 100% | 703.54 | 2631 / 2642 | 100% | 18.19 | 703 / 705 |
thymus | 100% | 723.52 | 653 / 653 | 99% | 14.28 | 596 / 605 |
breast | 100% | 611.05 | 459 / 459 | 98% | 18.54 | 1091 / 1118 |
pancreas | 100% | 752.60 | 327 / 328 | 97% | 13.86 | 173 / 178 |
intestine | 100% | 741.53 | 964 / 966 | 96% | 15.54 | 508 / 527 |
bladder | 100% | 789.19 | 21 / 21 | 96% | 16.30 | 483 / 504 |
skin | 100% | 910.18 | 1805 / 1809 | 96% | 19.05 | 453 / 472 |
uterus | 99% | 710.44 | 168 / 170 | 96% | 19.68 | 441 / 459 |
esophagus | 100% | 627.32 | 1441 / 1445 | 94% | 13.10 | 172 / 183 |
kidney | 100% | 955.15 | 89 / 89 | 94% | 12.03 | 843 / 901 |
stomach | 99% | 603.19 | 357 / 359 | 94% | 14.30 | 268 / 286 |
adrenal gland | 100% | 1205.30 | 258 / 258 | 92% | 15.12 | 211 / 230 |
lung | 88% | 431.42 | 510 / 578 | 94% | 14.76 | 1084 / 1155 |
liver | 90% | 458.39 | 203 / 226 | 60% | 5.86 | 243 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.87 | 29 / 29 |
spleen | 100% | 784.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.76 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.87 | 1 / 1 |
adipose | 100% | 519.93 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 384.44 | 1309 / 1335 | 0% | 0 | 0 / 0 |
heart | 88% | 248.80 | 754 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 9.64 | 68 / 80 |
peripheral blood | 54% | 480.36 | 501 / 929 | 0% | 0 | 0 / 0 |
muscle | 36% | 61.68 | 292 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010821 | Biological process | regulation of mitochondrion organization |
GO_2000059 | Biological process | negative regulation of ubiquitin-dependent protein catabolic process |
GO_0032259 | Biological process | methylation |
GO_0045652 | Biological process | regulation of megakaryocyte differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0019919 | Biological process | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine |
GO_0036211 | Biological process | protein modification process |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0090398 | Biological process | cellular senescence |
GO_0006284 | Biological process | base-excision repair |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0070612 | Molecular function | histone H2AR3 methyltransferase activity |
GO_0070611 | Molecular function | histone H3R2 methyltransferase activity |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0035241 | Molecular function | protein-arginine omega-N monomethyltransferase activity |
GO_0042054 | Molecular function | histone methyltransferase activity |
GO_0008469 | Molecular function | histone arginine N-methyltransferase activity |
GO_0016274 | Molecular function | protein-arginine N-methyltransferase activity |
GO_0140938 | Molecular function | histone H3 methyltransferase activity |
GO_0035242 | Molecular function | protein-arginine omega-N asymmetric methyltransferase activity |
GO_0044020 | Molecular function | histone H4R3 methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRMT6 |
Protein name | Protein arginine N-methyltransferase 6 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT6) Protein arginine N-methyltransferase 6 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 6) (Histone-arginine N-methyltransferase PRMT6) |
Synonyms | HRMT1L6 |
Description | FUNCTION: Arginine methyltransferase that can catalyze the formation of both omega-N monomethylarginine (MMA) and asymmetrical dimethylarginine (aDMA), with a strong preference for the formation of aDMA . Preferentially methylates arginyl residues present in a glycine and arginine-rich domain and displays preference for monomethylated substrates . Specifically mediates the asymmetric dimethylation of histone H3 'Arg-2' to form H3R2me2a . H3R2me2a represents a specific tag for epigenetic transcriptional repression and is mutually exclusive with methylation on histone H3 'Lys-4' (H3K4me2 and H3K4me3) . Acts as a transcriptional repressor of various genes such as HOXA2, THBS1 and TP53 . Repression of TP53 blocks cellular senescence (By similarity). Also methylates histone H2A and H4 'Arg-3' (H2AR3me and H4R3me, respectively). Acts as a regulator of DNA base excision during DNA repair by mediating the methylation of DNA polymerase beta (POLB), leading to the stimulation of its polymerase activity by enhancing DNA binding and processivity . Methylates HMGA1 . Regulates alternative splicing events. Acts as a transcriptional coactivator of a number of steroid hormone receptors including ESR1, ESR2, PGR and NR3C1. Promotes fasting-induced transcriptional activation of the gluconeogenic program through methylation of the CRTC2 transcription coactivator (By similarity). May play a role in innate immunity against HIV-1 in case of infection by methylating and impairing the function of various HIV-1 proteins such as Tat, Rev and Nucleocapsid protein p7 (NC) . Methylates GPS2, protecting GPS2 from ubiquitination and degradation (By similarity). Methylates SIRT7, inhibiting SIRT7 histone deacetylase activity and promoting mitochondria biogenesis . . |
Accessions | ENST00000370078.2 [Q96LA8-1] A0A3B3ITK4 ENST00000650338.1 Q96LA8 |